In a significant legal development, the Delhi High Court on Monday dismissed a petition filed by PB Agro LLP, the manufacturer of Vimal Elaichi. The company had approached the court to quash show-cause notices issued by the Maharashtra Food and Drug Administration (FDA) to its high-profile brand ambassadors, including superstars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff.

The controversy stems from allegations of 'surrogate advertising.' The Maharashtra FDA contends that the advertisements for Vimal Elaichi are merely a front to promote Vimal Pan Masala, a product that is banned in the state. The regulator had directed the actors to provide documentation proving that the cardamom product is distinct from the banned pan masala products.

Why This Matters

BozokMedia analysis shows that this case highlights the intensifying battle between regulatory bodies and large corporations over the loophole of surrogate advertising. As celebrities wield immense influence, the legal responsibility of endorsers in promoting products that mimic banned substances is becoming a critical area of judicial scrutiny.

Legal experts suggest that the dismissal on jurisdictional grounds sets a precedent that companies cannot bypass state-specific regulations by moving cases to different territories.

Justice Swarana Kanta Sharma presided over the matter, noting that the petition was not maintainable in Delhi. The court emphasized the doctrine of forum conveniens, stating that since the notices were issued by the Mumbai-based FDA and the brand ambassadors are residents of Mumbai, the Maharashtra courts are the most appropriate venue for the grievance.

PB Agro LLP had argued in its petition that its endorsement agreements were in full compliance with the law and that the allegations of surrogate advertising were baseless. The company maintained that Vimal Pan Masala has not been manufactured or sold in Maharashtra since 2001, and that the Supreme Court has banned tobacco-containing pan masala nationwide since 2013.

However, the court declined to rule on the merits of these arguments. The judge observed that the petitioner failed to demonstrate how any substantial part of the cause of action arose within the territorial jurisdiction of the Delhi High Court, despite attempts to involve central authorities based in Delhi.

Frequently Asked Questions

1. What is the main allegation against Vimal Elaichi?
The Maharashtra FDA alleges that the brand uses 'Vimal Elaichi' as a surrogate to promote 'Vimal Pan Masala,' which is banned in the state.

2. Why did the Delhi High Court refuse to hear the case?
The court ruled it lacked territorial jurisdiction because the regulator (FDA) and the subjects (the actors) are based in Maharashtra.